First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 166.41 USD 1.06% Market Closed
Updated: Apr 20, 2024

Abbvie Inc
Short-Term Investments

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
|

Abbvie Inc
Short-Term Investments Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Short-Term Investments
$2m
CAGR 3-Years
-59%
CAGR 5-Years
-70%
CAGR 10-Years
-39%
Gilead Sciences Inc
NASDAQ:GILD
Short-Term Investments
$1.2B
CAGR 3-Years
-6%
CAGR 5-Years
-37%
CAGR 10-Years
51%
Amgen Inc
NASDAQ:AMGN
Short-Term Investments
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Short-Term Investments
$849.2m
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
-1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Short-Term Investments
$8.1B
CAGR 3-Years
80%
CAGR 5-Years
43%
CAGR 10-Years
48%
Seagen Inc
NASDAQ:SGEN
Short-Term Investments
$808.4m
CAGR 3-Years
0%
CAGR 5-Years
18%
CAGR 10-Years
12%

See Also

What is Abbvie Inc's Short-Term Investments?
Short-Term Investments
2m USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Short-Term Investments amounts to 2m USD.

What is Abbvie Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 10Y
-39%

Over the last year, the Short-Term Investments growth was -93%. The average annual Short-Term Investments growth rates for Abbvie Inc have been -59% over the past three years , -70% over the past five years , and -39% over the past ten years .